The present study used quantitative in situ analysis to reveal for the first time a significant reduction in total cellular and nuclear Stat5a protein levels in invasive breast cancer and lymph node metastases compared with normal breast epithelia and DCIS. The gene discussed is STAT5A; the disease is ductal breast carcinoma in situ.